Covid-19 Impact on Digital Therapeutics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Digital Therapeutics, including the following market information:
Major competitors identified in this market include Proteus Digital Health, Omada Health, WellDoc, 2Morrow, Livongo Health, Propeller Health, Twine Health, Canary Health, etc.
Based on the Region:
- Global Digital Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Digital Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Digital Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Digital Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Proteus Digital Health, Omada Health, WellDoc, 2Morrow, Livongo Health, Propeller Health, Twine Health, Canary Health, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Software
- Devices
- Diabetes
- Obesity
- Cardio Vascular Diseases (CVD)
- Central Nervous System (CNS) Disease
- Gastrointestinal Disorders (GID)
- Respiratory Diseases
- Smoking Cessation
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Digital Therapeutics Industry
1.7 COVID-19 Impact: Digital Therapeutics Market Trends
2 GLOBAL DIGITAL THERAPEUTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Digital Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Digital Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Digital Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Digital Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Digital Therapeutics Market
3.4 Key Players Digital Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DIGITAL THERAPEUTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Software
1.4.2 Devices
4.2 By Type, Global Digital Therapeutics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DIGITAL THERAPEUTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Diabetes
5.5.2 Obesity
5.5.3 Cardio Vascular Diseases (CVD)
5.5.4 Central Nervous System (CNS) Disease
5.5.5 Gastrointestinal Disorders (GID)
5.5.6 Respiratory Diseases
5.5.7 Smoking Cessation
5.5.8 Others
5.2 By Application, Global Digital Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Digital Therapeutics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Proteus Digital Health
7.1.1 Proteus Digital Health Business Overview
7.1.2 Proteus Digital Health Digital Therapeutics Quarterly Revenue, 2020
7.1.3 Proteus Digital Health Digital Therapeutics Product Introduction
7.1.4 Proteus Digital Health Response to COVID-19 and Related Developments
7.2 Omada Health
7.2.1 Omada Health Business Overview
7.2.2 Omada Health Digital Therapeutics Quarterly Revenue, 2020
7.2.3 Omada Health Digital Therapeutics Product Introduction
7.2.4 Omada Health Response to COVID-19 and Related Developments
7.3 WellDoc
7.3.1 WellDoc Business Overview
7.3.2 WellDoc Digital Therapeutics Quarterly Revenue, 2020
7.3.3 WellDoc Digital Therapeutics Product Introduction
7.3.4 WellDoc Response to COVID-19 and Related Developments
7.4 2Morrow
7.4.1 2Morrow Business Overview
7.4.2 2Morrow Digital Therapeutics Quarterly Revenue, 2020
7.4.3 2Morrow Digital Therapeutics Product Introduction
7.4.4 2Morrow Response to COVID-19 and Related Developments
7.5 Livongo Health
7.5.1 Livongo Health Business Overview
7.5.2 Livongo Health Digital Therapeutics Quarterly Revenue, 2020
7.5.3 Livongo Health Digital Therapeutics Product Introduction
7.5.4 Livongo Health Response to COVID-19 and Related Developments
7.6 Propeller Health
7.6.1 Propeller Health Business Overview
7.6.2 Propeller Health Digital Therapeutics Quarterly Revenue, 2020
7.6.3 Propeller Health Digital Therapeutics Product Introduction
7.6.4 Propeller Health Response to COVID-19 and Related Developments
7.7 Twine Health
7.7.1 Twine Health Business Overview
7.7.2 Twine Health Digital Therapeutics Quarterly Revenue, 2020
7.7.3 Twine Health Digital Therapeutics Product Introduction
7.7.4 Twine Health Response to COVID-19 and Related Developments
7.8 Canary Health
7.8.1 Canary Health Business Overview
7.8.2 Canary Health Digital Therapeutics Quarterly Revenue, 2020
7.8.3 Canary Health Digital Therapeutics Product Introduction
7.8.4 Canary Health Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Digital Therapeutics Industry
1.7 COVID-19 Impact: Digital Therapeutics Market Trends
2 GLOBAL DIGITAL THERAPEUTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Digital Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Digital Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Digital Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Digital Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Digital Therapeutics Market
3.4 Key Players Digital Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DIGITAL THERAPEUTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Software
1.4.2 Devices
4.2 By Type, Global Digital Therapeutics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DIGITAL THERAPEUTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Diabetes
5.5.2 Obesity
5.5.3 Cardio Vascular Diseases (CVD)
5.5.4 Central Nervous System (CNS) Disease
5.5.5 Gastrointestinal Disorders (GID)
5.5.6 Respiratory Diseases
5.5.7 Smoking Cessation
5.5.8 Others
5.2 By Application, Global Digital Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Digital Therapeutics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Proteus Digital Health
7.1.1 Proteus Digital Health Business Overview
7.1.2 Proteus Digital Health Digital Therapeutics Quarterly Revenue, 2020
7.1.3 Proteus Digital Health Digital Therapeutics Product Introduction
7.1.4 Proteus Digital Health Response to COVID-19 and Related Developments
7.2 Omada Health
7.2.1 Omada Health Business Overview
7.2.2 Omada Health Digital Therapeutics Quarterly Revenue, 2020
7.2.3 Omada Health Digital Therapeutics Product Introduction
7.2.4 Omada Health Response to COVID-19 and Related Developments
7.3 WellDoc
7.3.1 WellDoc Business Overview
7.3.2 WellDoc Digital Therapeutics Quarterly Revenue, 2020
7.3.3 WellDoc Digital Therapeutics Product Introduction
7.3.4 WellDoc Response to COVID-19 and Related Developments
7.4 2Morrow
7.4.1 2Morrow Business Overview
7.4.2 2Morrow Digital Therapeutics Quarterly Revenue, 2020
7.4.3 2Morrow Digital Therapeutics Product Introduction
7.4.4 2Morrow Response to COVID-19 and Related Developments
7.5 Livongo Health
7.5.1 Livongo Health Business Overview
7.5.2 Livongo Health Digital Therapeutics Quarterly Revenue, 2020
7.5.3 Livongo Health Digital Therapeutics Product Introduction
7.5.4 Livongo Health Response to COVID-19 and Related Developments
7.6 Propeller Health
7.6.1 Propeller Health Business Overview
7.6.2 Propeller Health Digital Therapeutics Quarterly Revenue, 2020
7.6.3 Propeller Health Digital Therapeutics Product Introduction
7.6.4 Propeller Health Response to COVID-19 and Related Developments
7.7 Twine Health
7.7.1 Twine Health Business Overview
7.7.2 Twine Health Digital Therapeutics Quarterly Revenue, 2020
7.7.3 Twine Health Digital Therapeutics Product Introduction
7.7.4 Twine Health Response to COVID-19 and Related Developments
7.8 Canary Health
7.8.1 Canary Health Business Overview
7.8.2 Canary Health Digital Therapeutics Quarterly Revenue, 2020
7.8.3 Canary Health Digital Therapeutics Product Introduction
7.8.4 Canary Health Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Digital Therapeutics Assessment
Table 9. COVID-19 Impact: Digital Therapeutics Market Trends
Table 10. COVID-19 Impact Global Digital Therapeutics Market Size
Table 11. Global Digital Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Digital Therapeutics Market Growth Drivers
Table 14. Global Digital Therapeutics Market Restraints
Table 15. Global Digital Therapeutics Market Opportunities
Table 16. Global Digital Therapeutics Market Challenges
Table 17. By Players, Digital Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Digital Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Digital Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Digital Therapeutics Market
Table 21. Key Players Digital Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Digital Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Digital Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Digital Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Proteus Digital Health Business Overview
Table 58. Proteus Digital Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Proteus Digital Health Digital Therapeutics Product
Table 60. Proteus Digital Health Response to COVID-19 and Related Developments
Table 61. Omada Health Business Overview
Table 62. Omada Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Omada Health Digital Therapeutics Product
Table 64. Omada Health Response to COVID-19 and Related Developments
Table 65. WellDoc Business Overview
Table 66. WellDoc Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. WellDoc Digital Therapeutics Product
Table 68. WellDoc Response to COVID-19 and Related Developments
Table 69. 2Morrow Business Overview
Table 70. 2Morrow Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. 2Morrow Digital Therapeutics Product
Table 72. 2Morrow Response to COVID-19 and Related Developments
Table 73. Livongo Health Business Overview
Table 74. Livongo Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Livongo Health Digital Therapeutics Product
Table 76. Livongo Health Response to COVID-19 and Related Developments
Table 77. Propeller Health Business Overview
Table 78. Propeller Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Propeller Health Digital Therapeutics Product
Table 80. Propeller Health Response to COVID-19 and Related Developments
Table 81. Twine Health Business Overview
Table 82. Twine Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Twine Health Digital Therapeutics Product
Table 84. Twine Health Response to COVID-19 and Related Developments
Table 85. Canary Health Business Overview
Table 86. Canary Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Canary Health Digital Therapeutics Product
Table 88. Canary Health Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Digital Therapeutics Assessment
Table 9. COVID-19 Impact: Digital Therapeutics Market Trends
Table 10. COVID-19 Impact Global Digital Therapeutics Market Size
Table 11. Global Digital Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Digital Therapeutics Market Growth Drivers
Table 14. Global Digital Therapeutics Market Restraints
Table 15. Global Digital Therapeutics Market Opportunities
Table 16. Global Digital Therapeutics Market Challenges
Table 17. By Players, Digital Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Digital Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Digital Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Digital Therapeutics Market
Table 21. Key Players Digital Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Digital Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Digital Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Digital Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Digital Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Proteus Digital Health Business Overview
Table 58. Proteus Digital Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Proteus Digital Health Digital Therapeutics Product
Table 60. Proteus Digital Health Response to COVID-19 and Related Developments
Table 61. Omada Health Business Overview
Table 62. Omada Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Omada Health Digital Therapeutics Product
Table 64. Omada Health Response to COVID-19 and Related Developments
Table 65. WellDoc Business Overview
Table 66. WellDoc Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. WellDoc Digital Therapeutics Product
Table 68. WellDoc Response to COVID-19 and Related Developments
Table 69. 2Morrow Business Overview
Table 70. 2Morrow Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. 2Morrow Digital Therapeutics Product
Table 72. 2Morrow Response to COVID-19 and Related Developments
Table 73. Livongo Health Business Overview
Table 74. Livongo Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Livongo Health Digital Therapeutics Product
Table 76. Livongo Health Response to COVID-19 and Related Developments
Table 77. Propeller Health Business Overview
Table 78. Propeller Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Propeller Health Digital Therapeutics Product
Table 80. Propeller Health Response to COVID-19 and Related Developments
Table 81. Twine Health Business Overview
Table 82. Twine Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Twine Health Digital Therapeutics Product
Table 84. Twine Health Response to COVID-19 and Related Developments
Table 85. Canary Health Business Overview
Table 86. Canary Health Digital Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Canary Health Digital Therapeutics Product
Table 88. Canary Health Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Digital Therapeutics Product Picture
Figure 2. Digital Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Digital Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Digital Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Digital Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Digital Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Digital Therapeutics Market Size Market Share, 2019-2021
Figure 1. Digital Therapeutics Product Picture
Figure 2. Digital Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Digital Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Digital Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Digital Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Digital Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Digital Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Digital Therapeutics Market Size Market Share, 2019-2021
